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General Information.  Commercial reagents were purified prior to use following
the guidelines of Perrin and Armarego.1 Organic solutions were concentrated under
reduced pressure on a Büchi rotary evaporator.  Chloroform was distilled from calcium
hydride prior to use.  Chromatographic purification of products was accomplished using
forced-flow chromatography on ICN 60 32-64 mesh silica gel 63 according to the method
of Still.2 Thin-layer chromatography (TLC) was performed on EM Reagents 0.25 mm
silica gel 60-F plates.  Visualization of the developed chromatogram was performed by
fluorescence quenching or anisaldehyde stain.
1H and 13C NMR spectra were recorded on Varian Mercury 300 (300 MHz and 75
MHz respectively) as noted, and are internally referenced to residual protio solvent
signals.  Data for 1H are reported as follows: chemical shift (δ ppm), multiplicity (s =
singlet, d = doublet, t = triplet, q = quartet, m = multiplet), integration, coupling constant
(Hz) and assignment.  Data for 13C NMR are reported in terms of chemical shift.  IR
spectra were recorded on a Perkin Elmer Paragon 1000 spectrometer and are reported in
terms of frequency of absorption (cm-1).  Mass spectra were obtained from the California
Institute of Technology Mass Spectral facility. Gas liquid chromatography (GLC) was
performed on Hewlett-Packard 6850 and 6890 Series gas chromatographs equipped with
a split-mode capillary injection system and flame ionization detectors using a Bodman
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Chiraldex β-DM or Γ-TA (30 m x 0.25 mm) column.  High performance liquid
chromatography (HPLC) was performed on Hewlett-Packard 1100 Series
chromatographs using Chiralcel AD column (1.6 x 25 cm) and AD guard (1.6 x 5 cm),
Chiralcel OD−H (1.6 x 25 cm) and OD guard (1.6 x 5 cm), or Chiralcel AS (1.6 x 25 cm)
and AS guard (1.6 x 5 cm) as noted.
Trimethyl-(5-ethyl-furan-2-yloxy)-silane.  To a round bottom flask equipped
with a magnetic stir bar and charged with CH2Cl2 (50 mL) was added 5-ethyl-5H-furan-2-
one3 (6.5 g, 58 mmol) and triethylamine (11 mL, 81 mmol), which was cooled to 0 °C.
Trimethylsilyl trifluoromethanesulfonate (12 mL, 64 mmol) was added slowly and
allowed to stir at room temperature for 6 hours. The reaction mixture was concentrated in
vacuo and the top layer was decanted and purified by distillation (14 mmHg, 94 °C) to
provide the title compound as a pale yellow oil (7.6 g, 71% yield).
(3,5-Dimethyl-furan-2-yloxy)-trimethyl-silane. To a round bottom flask
equipped with a magnetic stir bar and charged with CH2Cl2 (5 mL) was added 3,5-
dimethyl-3H-furan-2-one4 (0.56 g, 5.0 mmol) and triethylamine (0.97 mL, 7.0 mmol),
which was cooled to 0 °C.  Trimethylsilyl trifluoromethanesulfonate (0.99 mL, 5.5
mmol) was added slowly and allowed to stir at room temperature for 6 hours. The
reaction mixture was concentrated in vacuo and the top layer was decanted and purified
by distillation (40 mmHg, 85 °C) to provide the title compound as a colorless oil (0.62 g,
68% yield).
General Procedure: To a 2-dram vial equipped with a magnetic stir bar and
charged with (2S , 5S)-5-benzyl-2-tert-butyl-3-methyl-imidazolidin-4-one was added
solvent, 2,4-dinitrobenzoic acid and aldehyde, then placed in a bath at the appropriate
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temperature.  The solution was stirred for 10 min before the addition of the siloxy-furan
substrate in one portion.  The resulting solution was stirred at constant temperature until
reaction was determined to be complete by GLC conversion assay using dibenzyl ether as
an internal standard.  The reaction mixture was then transferred cold through a silica gel
plug with ether into a flask and carefully concentrated in vacuo.  The resulting residue
was purified by silica gel chromatography (solvents noted) and fractions carefully
concentrated in vacuo to provide the title compounds.  The enantioselectivity was
determined by chiral GLC  analysis.
(3R, 2'R)-3-(2'-Methyl-5'-oxo-2', 5'-dihydro-furan-2'-yl)-butyraldehyde
(Table 2, Entry 1).  Prepared according to the general procedure from (E )-
crotonaldehyde (166 µL, 2.00 mmol), trimethyl-(5-methyl-furan-2-yloxy)-silane (184 µL,
1.00 mmol), (2S, 5S)-5-benzyl-2-tert-butyl-3-methyl-imidazolidin-4-one (49.2 mg, 0.200
mmol), 2,4-dinitrobenzoic acid (42.4 mg, 0.20 mmol), H2O (36.0 µL, 2.00 mmol), and
CH2Cl2 (4.0 mL) at −70 °C for 11 h to provide the title compound as a colorless oil
(135.5 mg, 81% yield, 22 : 1 dr, 92% ee) after silica gel chromatography (40% EtOAc/
hexanes).  IR (film) 3082, 2968, 2729, 1752, 1721, 1379, 1249, 1119, 948.1, 818.4 cm-1;
1H NMR (300 MHz, CDCl3) δ 9.75 (s, 1H, CHO), 7.38 (d, J = 5.5 Hz, 1H, CHCHCO2),
6.09 (d, J = 5.5 Hz, 1H, CHCHCO2), 2.66- 2.52 (m, 2H, MeCH, CH2), 1.97- 1.82 (ddd, J
= 2.2, 9.9, 18.7 Hz, 1H, CH2), 1.47 (s, 3H, OCCH3); 0.99 (d, J = 7.1 Hz, 3H, CHCH3);
13C NMR (75 MHz, CDCl3) δ 200.5, 158.7, 121.8, 100.2, 90.7, 46.0, 35.0, 23.2, 16.2;
HRMS (CI) exact mass calcd for (C9H12O3) requires m/z 168.0786, found m/z 168.0781.
[α]D = + 46 9 (c = 1.0, CHCl3).  The enantiomeric ratio was determined by GLC using a
Bodman Chiraldex Γ-TA (30 m x 0.25 mm) column (100 °C isotherm for 7 min then 160
°C isotherm , 1 mL/min); (3S, 2'S) isomer tr = 22.8 min and (3R, 2'R) isomer tr = 23.8
min.
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(3R, 2'R)-3-(2'-Methyl-5'-oxo-2', 5'-dihydro-furan-2'-yl)-hexanal (Table 2,
Entry 2).      Prepared according to the general procedure from (E)-hexenal (348 µL, 3.00
mmol), trimethyl-(5-methyl-furan-2-yloxy)-silane (184 µL, 1.00 mmol), (2S, 5S)-5-
benzyl-2-tert-butyl-3-methyl-imidazolidin-4-one (49.2 mg, 0.200 mmol), 2,4-
dinitrobenzoic acid (42.4 mg, 0.20 mmol), H2O (36.0 µL, 2.00 mmol), and CH2Cl2 (4.0
mL) at −50 °C for 20 h to provide the title compound as a colorless oil (170.0 mg, 87%
yield, 31 : 1 dr, 84% ee) after silica gel chromatography (40% EtOAc/hexanes).  IR (film)
3093, 2960, 2863, 2722, 1757, 1722, 1602, 1455, 1380, 1286, 1247, 1198, 1119, 1094,
1034, 951.8, 821.8 cm-1; 1H NMR (300 MHz, CDCl3) δ 9.57 (t, J = 1.6 Hz, 1H, CHO),
7.31 (d, J = 5.5 Hz, 1H, CHCHCO2), 5.92 (d, J = 5.5 Hz, 1H, CHCHCO2), 2.36- 2.14 (m,
3H, CHCH2CHO), 1.38- 0.98 (m, 4H, CH2CH2), 1.32 (s, 3H, OCCH3); 0.74 (t, J = 7.1
Hz, 3H, CH2CH3); 13C NMR (75 MHz, CDCl3) δ 200.8, 171.9, 159.4, 121.5, 91.0, 44.1,
30.0, 33.0, 23.2, 21.2, 14.3;  HRMS (CI) exact mass calcd for (C11H16O3) requires m/z
196.1100, found m/z 196.1093.  [α]D = + 21.1 (c = 1.0, CHCl3).  The enantiomeric ratio
was determined by GLC using a Bodman Chiraldex Γ-TA (30 m x 0.25 mm) column
(170 °C isotherm, 1 mL/min); (3S, 2'S) isomer tr = 13.4 min and (3R, 2'R) isomer tr = 14.7
min.
(3S, 2'R)-4-Methyl-3-(2'-methyl-5'-oxo-2', 5'-dihydro-furan-2'-yl)-pentanal
(Table 2, Entry 3).  Prepared according to the general procedure from (E)-4-methyl-2-
pentenal (350 µL, 3.00 mmol), trimethyl-(5-methyl-furan-2-yloxy)-silane (184 µL, 1.00
mmol), (2S, 5S)-5-benzyl-2-tert-butyl-3-methyl-imidazolidin-4-one (49.2 mg, 0.200
mmol), 2,4-dinitrobenzoic acid (42.4 mg, 0.20 mmol), H2O (36.0 µL, 2.00 mmol), and
toluene (4.0 mL) at −20 °C for 30 h to provide the title compound as a colorless oil
(156.1 mg, 80% yield, 7 : 1 dr, 98% ee) after silica gel chromatography (40% EtOAc/
J. Am. Chem. Soc. Supporting Information S 5
hexanes). IR (film) 3093, 2963, 2874, 2722, 1758, 1723, 1602, 1467, 1389, 1371, 1260,
1236, 1115, 1088, 1040, 953.0, 822.4 cm-1; 1H NMR (300 MHz, CDCl3) δ 9.60 (t, J = 1.6
Hz, 1H, CHO), 7.31 (d, J  = 5.5 Hz, 1H, CH CHCO2), 5.92 (d, J  = 5.5 Hz, 1H,
CHCHCO2), 2.43 (ddd, J = 2.7, 6.0, 8.8 Hz, 1H, CHCHCH2), 2.24 (dd, , J = 1.6, 6.0, 8.8
Hz, 2H, CH2), 1.88-1.74 (m, 1H, CH(CH3)2), 1.30 (s, 3H, OCCH3); 0.78 (s, J = 7.1 Hz,
3H, CH(CH3)2); 0.64 (s, J = 7.1 Hz, 3H, CH(CH3)2); 13C NMR (75 MHz, CDCl3) δ 201.1,
171.9, 159.8, 121.3, 91.8, 44.7, 39.5, 28.1, 24.5, 23.3, 17.9;  HRMS (EI) exact mass calcd
for (C11H16O3) requires m/z 196.1099, found m/z 196.1093.  [α]D = + 12.8 (c = 1.0,
CHCl3).  The enantiomeric ratio was determined by GLC using a Bodman Chiraldex Γ-
TA (30 m x 0.25 mm) column (170 °C isotherm, 1 mL/min); (3S, 2'S) isomer tr = 12.2
min and (3R, 2'R) isomer tr = 13.8 min.
(3S, 2'R)-3-(2'-methyl-5'-oxo-2', 5'-dihydro-furan-2'-yl)-3-phenyl-
propionaldehyde (Table 2, Entry 4).  Prepared according to the general procedure from
(E)-cinnamaldehyde (378 µL, 3.00 mmol), trimethyl-(5-methyl-furan-2-yloxy)-silane
(184 µL, 1.00 mmol), (2S, 5S)-5-benzyl-2-tert-butyl-3-methyl-imidazolidin-4-one (49.2
mg, 0.200 mmol), 2,4-dinitrobenzoic acid (42.4 mg, 0.20 mmol), H2O (36.0 µL, 2.00
mmol), and trichloroethylene (4.0 mL) at −40 °C for 30 h to provide the title compound
as a colorless oil (177.1 mg, 77% yield, 6 : 1 dr, 99% ee) after silica gel chromatography
(40% EtOAc/hexanes). IR (film) 2831, 2722, 1757, 1723, 1602, 1602, 1493, 1454, 1378,
1226, 1106, 953.2, 820.7 cm-1; 1H NMR (300 MHz, CDCl3) δ 9.47 (s, 1H, CHO), 7.34-
7.16 (m, 5H, C5H5), 7.31 (d, J = 6.0 Hz, 1H, CHCHCO2), 5.98 (d, J = 5.5 Hz, 1H,
CHCHCO2), 3.50 (dd, , J = 5.5, 8.2 Hz, 3H, CHPh), 2.84 (ddd, J = 1.6, 8.8, 18.1 Hz, 1H,
CH2CHO), 2.84 (ddd, J = 1.1, 5.5, 18.1 Hz, 1H, CH2CHO), 1.22 (s, 3H, OCCH3); 13C
NMR (75 MHz, CDCl3) δ 200.0, 172.3, 161.0, 138.4, 129.5, 128.8, 127.9, 120.9, 90.2,
46.1, 44.7, 22.4; HRMS (CI) exact mass calcd for (C14H14O3) requires m/z 230.0943,
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found m/z 230.0934.  [α]D = + 69.7 (c = 1.0, CHCl3).  The enantiomeric ratio was
determined by GLC using a Bodman Chiraldex Γ-TA (30 m x 0.25 mm) column (170 °C
isotherm, 1 mL/min); (3R, 2'R) isomer tr = 61.7 min and (3S, 2'S) isomer tr = 64.0 min.
(2S, 2'R)-Benzoic acid 2-(2'-methyl-5'-oxo-2', 5'-dihydro-furan-2'-yl)-4-oxo-
butyl ester (Table 2, Entry 5).  Prepared according to the general procedure from (E)-4-
benzyloxy-but-2-enal (571 mg, 3.00 mmol), trimethyl-(5-methyl-furan-2-yloxy)-silane
(184 µL, 1.00 mmol), (2S, 5S)-5-benzyl-2-tert-butyl-3-methyl-imidazolidin-4-one (49.2
mg, 0.200 mmol), 2,4-dinitrobenzoic acid (42.4 mg, 0.20 mmol), H2O (36.0 µL, 2.00
mmol), and CH2Cl2 (4.0 mL) at −70 °C for 24 h to provide the title compound as a
colorless oil (248.8 mg, 86% yield, >20 : 1 dr, 90% ee) after silica gel chromatography
(40% EtOAc/hexanes). IR (film) 3071, 2982, 2939, 2849, 2736, 1758, 1721, 1602, 1452,
1384, 1315, 1273, 1177, 1112, 1071, 1026, 952.4, 822.7, 712.5 cm-1; 1H NMR (300 MHz,
CDCl3) δ  9.76 (s, 1H, CHO), 7.93 (d, J = 7.1 Hz, 2H, Ar), 7.60-7.38 (m, 4H, Ar,
CHCHCO2), 6.07 (d, J = 6.0 Hz, 1H, CHCHCO2), 4.41 (dd, J = 4.9, 12.1 Hz, 1H, OCH2),
4.22 (dd, J = 5.5, 12.1 Hz, 1H, OCH2), 3.04- 2.94 (m, 1H, CH2CHCH2), 2.72- 2.54 (m,
2H, CH2CHO), 1.54 (s, 3H, CCH3); 13C NMR (75 MHz, CDCl3) δ 199.4, 171.7, 166.1,
159.0, 133.7, 129.7, 129.4, 128.8, 121.5, 89.1, 63.9, 41.5, 39.4, 23.8; HRMS (CI) exact
mass calcd for (C16H16O5) requires m/z 288.0998, found m/z 288.1003. [α]D = + 45.6 (c =
1.0, CHCl3).  The enantiomeric ratio was determined by HPLC analysis of the alcohol,
obtained by NaBH4 reduction  of the aldehyde, using a Chiracel AS and AS guard
column (10% ethanol / hexanes, 1 mL/min); (2S, 2'R) isomer tr = 47.9 min and (2R, 2'S)
isomer tr = 67.0 min.
(2S, 2'R)-2-(2'-methyl-5'-oxo-2', 5'-dihydro-furan-2'-yl)-4-oxo-butyric acid
methyl ester (Table 2, Entry 6).  Prepared according to the general procedure from (E)-
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methyl-4-oxo-butenoate 9 (228.2 mg, 2.00 mmol), trimethyl-(5-methyl-furan-2-yloxy)-
silane (184 µL, 1.00 mmol), (2S, 5S)-5-benzyl-2-tert-butyl-3-methyl-imidazolidin-4-one
(49.2 mg, 0.200 mmol), 2,4-dinitrobenzoic acid (42.4 mg, 0.20 mmol), H2O (36.0 µL,
2.00 mmol), and trichloroethylene (2.0 mL) at −60 °C for 22 h to provide the title
compound as a colorless oil (178.2 mg, 84% yield, 11 : 1 dr, 99% ee) after silica gel
chromatography (40% EtOAc/hexanes).  IR (film) 3434, 3085, 2954, 2849, 2725, 1760,
1734, 1604, 1437, 1364, 1245, 1172, 1112, 1094, 1045, 956.3, 821.9 cm-1; 1H NMR (300
MHz, CDCl3) δ 9.72 (s, 1H, CHO), 7.58 (d, J = 5.5 Hz, 1H, CHCHCO2), 6.05 (d, J = 5.5
Hz, 1H, CHCHCO2), 3.72 (s, 3H, OCH3), 3.17- 2.79 (m, 3H, CHCH2CHO), 1.42 (s, 3H,
OCCH3); 13C NMR (75 MHz, CDCl3) δ 198.7, 171.3, 170.7, 160.0, 120.7, 87.0, 52.9,
46.8, 41.7, 21.0; HRMS (CI) exact mass calcd for (C10H12O5) requires m/z 212.0684,
found m/z 212.0685. [α]D = + 50.9 (c = 1.0, CHCl3).  The enantiomeric ratio was
determined by GLC using a Bodman Chiraldex β-DM (30 m x 0.25 mm) column (130 °C
isotherm, 1 mL/min); (2R, 2'S) isomer tr = 48.6 min and (2S, 2'R) isomer tr = 50.8 min.
(3S, 2'R)-4-Methyl-3-(5-oxo-2,5-dihydro-furan-2-yl)-pentanal (Table 3, Entry
1).  Prepared according to the general procedure from (E)-4-methyl-2-pentenal (351 µL,
3.00 mmol), 2-(trimethylsilyloxy)furan (168 µL, 1.00 mmol), (2S, 5S)-5-benzyl-2-tert-
butyl-3-methyl-imidazolidin-4-one (49.2 mg, 0.200 mmol), dichloroacetic  acid (16.5 µL,
0.20 mmol), H2O (90.0 µL, 5.00 mmol), and CHCl3 (1.91 mL) at −50 °C for 7 h to
provide the title compound as a colorless oil (127.2 mg, 70% yield, 7.3 : 1 dr, 90% ee)
after silica gel chromatography (40% EtOAc/hexanes).  IR (film) 2963, 2870, 2821,
2731, 1753, 1721, 1599, 1467, 1391, 1372, 1325, 1265, 1250, 1163, 1103, 1024, 985.4,
905.2, 819.6 cm-1; 1H NMR (300 MHz, CDCl3) δ 9.72 (s, 1H, CHO), 7.39 (dd, J = 1.4,
5.5 Hz, 1H, CHCHCO2), 6.10 (dd, J = 1.6, 5.8 Hz, 1H, CHCHCO2), 5.22 (m, 1H, OCH),
2.47- 2.23 (m, 2H, CH2), 1.97- 1.82 (m, 1H, CHMe2), 1.03 (d, J  = 6.6 Hz, 3H,
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CH(CH3)2); 0.99 (d, J = 6.9 Hz, 3H, CH(CH3)2); 13C NMR (75 MHz, CDCl3) δ 200.8,
173.1, 156.8, 122.0, 84.0, 40.7, 40.3, 30.4, 20.7, 20.3;  HRMS (CI) exact mass calc'd for
(C10H14O3) requires m/z 182.0943, found m/z 182.0937.  [α]D = − 87.4 (c = 1.0, CHCl3).
The enantiomeric ratio was determined by GLC using a Bodman Chiraldex Β-DM (30 m
x 0.25 mm) column (170 °C isotherm, 1 mL/min); (3R, 2'S) isomer tr = 6.7 min and (3S,
2'R) isomer tr = 7.0 min.
(3R, 2'R)-3-(2'-Ethyl-5'-oxo-2', 5'-dihydro-furan-2'-yl)-butyraldehyde (Table
3, Entry 3).  Prepared according to the general procedure from (E)-crotonaldehyde (248
µL, 3.00 mmol), trimethyl-(5-ethyl-furan-2-yloxy)-silane (184 mg, 1.00 mmol), (2S, 5S)-
5-benzyl-2-tert-butyl-3-methyl-imidazolidin-4-one (49.2 mg, 0.200 mmol), 2,4-
dinitrobenzoic acid (42.4 mg, 0.20 mmol), H2O (36.0 µL, 2.00 mmol), and CH2Cl2 (6.0
mL) at −70 °C for 11 h to provide the title compound as a colorless oil (155.7 mg, 83%
yield, 16 : 1 dr, 90% ee) after silica gel chromatography (40% EtOAc/hexanes). IR (film)
3093, 2978, 2929, 2874, 2722, 1759, 1724, 1602, 1460, 1384, 1218, 1124, 975.9, 918.7,
822.2 cm-1; 1H NMR (300 MHz, CDCl3) δ 9.57 (t, J = 1.6 Hz, 1H, CHO), 7.26 (d, J = 5.5
Hz, 1H, CHCHCO2), 6.00 (d, J = 5.5 Hz, 1H, CHCHCO2), 2.58- 2.46 (m, 1H, CHCH3),
2.38 (dd, J = 3.8, 17.6 Hz, 1H, CH 2CHO), 2.07 (ddd, J = 1.6, 8.8, 17.0 Hz, 1H,
CH2CHO), 1.90- 1.60 (m, 2H, CH2CH3), 0.85 (d, J = 6.6 Hz, 3H, CHCH3), 0.68 (t, J =
7.1 Hz, 3H, CH2CH3); 13C NMR (75 MHz, CDCl3) δ 200.8, 172.4, 157.7, 122.6, 93.4,
45.6, 33.5, 28.2, 16.0, 7.7; HRMS (CI) exact mass calc’d for (C10H14O3) requires m/z
182.0943, found m/z 182.0942. [α]D = + 25.5 (c = 1.0, CHCl3).  The enantiomeric ratio
was determined by GLC using a Bodman Chiraldex Γ-TA (30 m x 0.25 mm) column
(150 °C isotherm, 1 mL/min); (3S, 2'S) isomer tr = 27.0 min and (3R, 2'R) isomer tr = 29.8
min.
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(2S,1’R)-2-(1’-methyl-3’-oxo-propyl)-5-oxo-2,5-dihydrofuran-2-carboxylic
acid methyl ester (Table 3, Entry 4). Prepared according to the general procedure from
(E)-crotonaldehyde (81.0 µL, 0.981 mmol), 5-triisopropylsilanyloxy-furan-2-carboxylic
acid methyl ester 6 (97.5 mg, 0.327 mmol), the trifluoroacetic acid salt of (2S, 5S)-5-
benzyl-2-tert-butyl-3-methyl-imidazolidin-4-one (23.6 mg, 0.065 mmol), H2O (12.0 µL,
0.654 mmol), and THF (3.3 mL) at −10 °C for 44 h to provide the title compound as a
colorless oil (60.0 mg, 86% yield, 6 : 1 dr, 98% ee) after silica gel. IR (film):  3099, 2960,
2737, 1774, 1738, 1260, 1118, 1040, 908.8, 822.6  cm-1; 1H NMR (300 MHz, CDCl3) δ
9.71 (d, J = 0.9 Hz, 1H, CHO), 7.40 (d, J = 5.4 Hz, 1H, CH=CH), 6.19 (d, J = 5.4 Hz,
1H, CH=CH), 3.77 (s, 1H, CO2CH3), 3.05 (ddq, J = 6.6, 3.9, 3.9 Hz, 1H, CHCH2), 2.63
(dd, J = 18.0, 3.9 Hz, 1H, CHCHHCHO), ), 2.49 (ddd, J = 18.0, 3.9, 1.2 Hz, 1H,
CHCHHCHO), 0.83 (t, J = 6.6 Hz, 3H, CHCH3); 13C NMR (75 MHz, CDCl3) δ 199.2,
171.0, 167.6, 153.6, 122.6, 91.9, 53.4, 45.9, 32.4, 13.9; HRMS (CI) exact mass calc’d for
(C10H13O5) requires m/z 213.0763, found m/z 213.0763.  [α]D = −59.1 (c = 1.4, CHCl3).
The diastereomeric ratio was determined by 1H NMR.  The enantiomeric ratio was
determined by GLC analysis of the aldehyde using a Bodman Chiraldex Γ-TA (30 m x
0.25 mm) column (165 ˚C isotherm, 0.8 mL/min); (2S,1’R) isomer tr = 16.8 min, (2R,1’S)
isomer tr = 19.2 min.
(2R,1’R)-2-(1’-methyl-3’-oxo-propyl)-5-oxo-2,5-dihydrofuran-2-carboxylic
acid methyl ester (Table 3, Entry 5).  Prepared according to the general procedure from
(E)-crotonaldehyde (81.0 µL, 0.98 mmol), 5-triisopropylsilanyloxy-furan-2-carboxylic
acid methyl ester 6 (97.2 mg, 0.33 mmol), the trifluoromethanesulfonic acid salt of (2S,
5S)-5-benzyl-2-tert-butyl-3-methyl-imidazolidin-4-one (25.8 mg, 0.065 mmol), H2O
(11.7 µL, 0.65 mmol), and CHCl3 (3.3 mL, 0.1 M) at −10 °C for 4 d to provide the title
compound as a colorless oil (60.2 mg, 83% yield, 7 : 1 dr, 98% ee) after silica gel.  IR
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(film):  3099, 2960, 2734, 1773, 1738, 1254, 1117, 1038, 908.2, 821.5 cm-1; 1H NMR
(300 MHz, CDCl3) δ 9.67 (s, 1H, CHO), 7.38 (d, J = 5.4 Hz, 1H, CH=CH), 6.14 (d, J =
5.4 Hz, 1H, CH=CH), 3.79 (s, 1H, CO2CH3), 3.04 (ddq, J = 7.2, 6.6, 5.7 Hz, 1H,
CHCH2), 2.45 (dd, J = 18.6, 5.4 Hz, 1H, CHHCHO), 2.32 (ddd, J = 18.0, 7.2, 0.9 Hz,
1H, CHHCHO), 0.83 (t, J = 6.6 Hz, 3H, CHCH3); 13C NMR (75 MHz, CDCl3) δ 199.4,
170.8, 167.3, 154.2, 122.3, 92.1, 53.4, 44.3, 32.5, 15.9; HRMS (EI) exact mass calc’d for
(C10H12O5) requires m/z 212.0684, found m/z 212.0682.  [α]D = −79.5 (c = 1.4, CHCl3).
The diastereomeric ratio was determined by 1H NMR.  The enantiomeric ratio was
determined by GLC analysis of the aldehyde using a Bodman Chiraldex Γ-TA (30 m x
0.25 mm) column (165 ˚C isotherm, 0.8 mL/min); (2R,1’R) isomer tr = 17.9 min, (2S,1’S)
isomer tr = 19.7 min.
(3R, 2'R)-3-(2',4'-Dimethyl-5'-oxo-2', 5'-dihydro-furan-2'-yl)-butyraldehyde
(Table 3, Entry 6).  Prepared according to the general procedure from (E )-
crotonaldehyde (124 µL, 1.50 mmol), trimethyl-(3,5-dimethyl-furan-2-yloxy)-silane (102
mg, 0.500 mmol), (2S, 5S)-5-benzyl-2-tert-butyl-3-methyl-imidazolidin-4-one (24.6 mg,
0.100 mmol), 2,4-dinitrobenzoic acid (21.2 mg, 0.20 mmol), H2O (18.0 µL, 1.00 mmol),
and CH2Cl2 (2.0 mL) at −65 °C for 23 h to provide the title compound as a colorless oil
(66.5 mg, 73% yield, 24 : 1 dr, 90% ee) after silica gel chromatography (40%
EtOAc/hexanes). IR (film) 2980, 2929, 2885, 2831, 2732, 1754, 1723, 1662, 1449, 1378,
1324, 1258, 1138, 1089, 1069, 1051, 999.8, 941.6, 876.1, 761.5 cm-1; 1H NMR (300
MHz, CDCl3) δ  9.67 (dd, J  = 1.1, 2.2 Hz, 1H, CHO), 6.95 (q, J  = 1.6 Hz, 1H,
CHCCH3CO2), 2.54- 2.40 (m, 2H, CHCH2CHO), 2.15 (ddd, J = 2.2, 9.3, 17.6 Hz, 4H,
CH2CH2), 1.86 (d, J = 1.6 Hz, 3H, CH3CCO2), 1.39 (s, 3H, OCCH3), 0.94 (d, J = 7.1 Hz,
3H, CHCH3); 13C NMR (75 MHz, CDCl3) δ 200.8, 173.3, 151.2, 130.3, 88.2, 46.0, 35.3,
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23.2, 16.2, 11.0; HRMS (CI) exact mass calcd for (C10H14O3) requires m/z 182.0943,
found m/z 182.0933. [α]D = +22.3 (c = 1.0, CHCl3).  The enantiomeric ratio was
determined by GLC using a Bodman Chiraldex Γ-TA (30 m x 0.25 mm) column (130 °C
isotherm, 1 mL/min); (3R, 2'R) isomer tr = 48.9 min and (3S, 2'S) isomer tr = 61.9 min.
(2R,1’S)-2-(1’-tert-butoxycarbonyl-3’-oxo-propyl)-5-oxo-2,5-dihydrofuran-2-
carboxylic acid methyl ester (8).  To a stirring solution of the (2R, 5R)-5-benzyl-2-tert-
butyl-3-methyl-imidazolidin-4-one • TFA salt (72.3 mg, 0.200 mmol) and H2O (36 µL,
2.00 mmol) in THF (8 mL) was added 4-oxobut-2-enoic acid tert-butyl ester 7 (469 mg,
3.00 mmol) at room temperature.  The resulting solution was cooled to 4 ˚C before 5-
Triisopropylsilanyloxy-furan-2-carboxylic acid methyl ester 6 (300 mg, 1.01 mmol) was
added in 2 mL of THF.  The solution was stirred at 4 ˚C for 43 h then passed through a
pad of silica gel and concentrated.  After silica gel chromatography, aldehyde 8 was
isolated as a yellow solid after reconcentration from hexanes (268 mg, 90% yield, 11:1
d.r., 89% e.e.).  IR (film):  2918, 2852, 1775, 1733, 1720, 1458, 1366, 1239, 1145, 1108,
1021, 828.8  cm-1; 1H NMR (300 MHz, CDCl3) δ 9.69 (s, 1H, CHO), 7.60 (d, J = 5.7 Hz,
1H, CH=CH), 6.17 (d, J  = 6.3 Hz, 1H, CH=CH), 3.81 (dd, J = 9.9, 4.5 Hz, 1H,
CHCO2C(CH3)3), 3.79 (s, 3H, CO2CH3), 2.92 (dd, J = 18.0, 9.3 Hz, 1H, CHH-CHO),
2.58 (dd, J = 18.6, 3.9 Hz, 1H, CHH-CHO), 1.39 (s, 9H, C(CH3)3); 13C NMR (75 MHz,
CDCl3) δ 198.0, 170.5, 168.0, 166.8, 153.9, 122.3, 88.6, 83.4, 54.0, 45.0, 40.8, 28.0 (3);
HRMS (CI) exact mass calc’d for (C14H19O7) requires m/z 299.1131, found m/z 299.1121.
[α]D = +9.9 (c = 0.95, CHCl3).  The diastereomeric ratio was determined by GLC analysis
of the aldehyde using a Bodman Chiraldex Γ-TA (30 m x 0.25 mm) column (170 ˚C, 1.0
mL/min); (2R,1’S)/(2S,1’R) isomers tr= 28.2 min, (2S,1’S)/(2R,1’R) isomers tr = 30.3 min.
The enantiomeric ratio was determined by HPLC analysis of the 2,2-dimethylpropane
acetal, obtained by acetal formation on the aldehyde with 2,2-dimethylpropane-1,3-diol
J. Am. Chem. Soc. Supporting Information S 12
and paratoluenesulfonic acid, using a Chiralcel OD-H and OD-H guard column (1.5%
EtOH/hexanes, 214 nm, 1.0 mL/min); (2S,1’R) isomer tr = 19.6 min, (2R,1’S) isomer  tr =
16.6 min.
(2R,1’S)-2-(1’-tert-butoxycarbonyl-undec-3’-enyl)-5-oxo-2,5-dihydrofuran-2-
carboxylic acid methyl ester.  Chromous chloride (383 mg, 3.12 mmol) and N,N-
dimethyl formamide (243 µL, 3.12 mmol) were stirred in anhydrous THF (7.8 mL) under
an N2 atmosphere at room temperature for 1 h to generate the CrCl2:DMF complex5.  1,1-
diiodooctane6 (287 mg, 0.780 mmol) and aldehyde 8 (100 mg, 0.390 mmol) were added
in 1.3 mL of anhydrous THF .  TLC analysis showed consumption of the aldehyde after
3.5 h.  The reaction was quenched with H2O and the aqueous layer was extracted three
times with pentanes.  The pentane layers were dried (Na2SO4) and concentrated.  The title
compound was afforded as a white solid after silica gel chromatography (77 mg, 65%
yield).  IR (film):  2956, 2928, 2856, 1783, 1740, 1723, 1457, 1437, 1369, 1256, 1156,
1099 cm-1; 1H NMR (300 MHz, CDCl3) δ 7.67 (d, J = 5.4 Hz, 1H, CH=CH), 6.18 (d, J =
5.4 Hz, 1H, CH=CH), 5.46 (dt, J = 15.3, 6.6 Hz, 1H, CH2CH=CHCH2), 5.25 (dt, J =
15.6, 6.6 Hz, 1H, CH2CH=CHCH2), 3.77 (s, 3H, CO2CH3), 3.21 (dd, J = 9.6, 4.8 Hz, 1H,
CHCO2C(CH3)3), 2.20 (m, 2H, CHCH2CH=CH), 1.94 (dt, J =6.6, 6.0 Hz, 2H,
CH=CHCH2), 1.41 (s, 9H, CO2C(CH3)3), 1.24 (m, 10H, (CH2)5), 0.87 (t, J = 6.6 Hz, 3H,
CH2CH3); 13C NMR (75 MHz, CDCl3) δ 171.1, 169.7, 167.2, 153.7, 134.5, 124.9, 122.7,
89.4, 82.3, 53.7, 51.2, 32.8, 32.1, 30.7, 29.5, 29.4, 28.2 (3), 23.0, 14.4; HRMS (CI) exact
mass calc’d for (C22H35O6)+ requires m/z 395.2433, found m/z 395.2428.  [α]D = -3.9 (c =
0.98, CHCl3).
(2R,1’S)-2-(1’-tert-butoxycarbonyl-undecyl)-5-oxo-tetrahydrofuran-2-
carboxylic acid methyl ester.  A 25 mL round bottom flask equipped with a magnetic
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stir bar and containing the undecenyl tert-butyl ester (100 mg, 0.284 mmol) and activated
palladium on carbon (10 mg) was charged with degassed EtOAc (2.8 mL, 0.1M).  The
system was evacuated and purged with H2 gas three times.  TLC analysis showed the
reaction complete after 4.5 h, at which point the reaction mixture was filtered over a pad
of Celite and a pad of silica gel with EtOAc to afford the title compound as a clear oil
after concentration (94.0 mg, 92% yield).  IR (film):  2957, 2927, 2855, 1797, 1744,
1731, 1460, 1369, 1249, 1169, 1132, 1055 cm-1; 1H NMR (300 MHz, CDCl3) δ 3.78 (s,
3H, CO2CH3), 2.94 (dd, J = 10.8, 3.0 Hz, 1H, CH CO2C(CH3)3), 2.50 (m, 4H,
CH2CH2CO2C), 1.73 (m, 1H, CHCHH(CH2)8), 1.47 (m, 1H, CHCHH(CH2)8), 1.43 (s,
9H, CO2C(CH3)3), 1.23 (m, 16H, (CH2)8), 0.85 (t, J = 6.6 Hz, 3H, CH2CH3); 13C NMR
(75 MHz, CDCl3) δ 175.5, 171.1, 170.8, 86.7, 81.9, 53.2, 51.9, 32.1, 29.8, 29.8, 29.6,
29.6, 29.5, 28.4, 28.3, 28.2 (3), 22.9, 14.4; HRMS (CI) exact mass calc’d for (C22H39O6)+
requires m/z 399.2746, found m/z 399.2736.  [α]D = -21.4 (c = 1.1, CHCl3).
(-)-Spiculisporic acid (5). (2S,1’R)-2-(1’-tert-butoxycarbonyl-undecyl)-5-
oxo-tetrahydrofuran-2-carboxylic acid methyl ester (28.7 mg, 0.0805 mmol) was taken
up in 0.5 mL THF and 1 mL of 4N aqueous NaOH.  The biphasic mixture was refluxed at
100 ˚C for 5.5 h and then cooled to room temperature.  The reaction mixture was
acidified with 1N aqueous HCl to pH=1.  The aqueous layer was extracted four times
with EtOAc.  The organic layers were concentrated to a white solid.  The hydrolyzed
intermediate was dissolved in a small amount of THF and 2 mL of 1N aqueous HCl was
added.  The reaction mixture was refluxed at 100 ˚C for 3.5 h, after which it was cooled
to room temperature and extracted four times with EtOAc.  The organic layers were dried
(Na2SO4) and concentrated.  The product was recrystallized from hot water to yield the
title compound 5 as white crystals (20 mg, 76% yield).  IR (film): 2919, 2850, 1793,
1778, 1716, 1654, 1559, 1540, 1510, 1458, 1419, 1290, 1182, 927.3  cm-1; 1H NMR (300
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MHz, CD3OD) δ  3.01 (dd, J  = 10.8, 2.7 Hz, 11H, CH CO2H), 2.53 (m, 4H,
CH2CH2CO2C), 1.85 (m, 1H, CHCHH(CH2)8), 1.52 (m, 1H, CHCHH(CH2)8), 1.29 (m,
16H, (CH2)8), 0.90 (t, J = 6.6 Hz, 3H, CH2CH3); 13C NMR (75 MHz, CD3OD 3) δ 178.3,
175.3, 173.9, 88.1, 52.5, 33.3, 30.9, 30.8, 30.8, 30.7, 30.6, 30.5, 29.2, 29.0, 29.0, 23.9,
14.7; HRMS (FAB+) exact mass calc’d for (C17H29O6)+ requires m/z 329.1964, found m/z
329.1965.  [α]D = -10.9 (c = 0.427, EtOH).  Commercial (-)-spiculisporic acid: [α]D = -
10.2 (c = 1.0, EtOH).  1H, 13C, and IR spectra of synthetic 5 were identical to the
commercial spiculisporic acid.
(2S,1’S)-2-(1’-Methoxycarbonyl-3’-oxo-propyl)-5-oxo-2,5-dihydrofuran-2-
carboxylic acid methyl ester (10).  4-Oxobut-2-enoic acid methyl ester 9 (574 mg, 5.03
mmol) was added to a stirring solution of (2R , 5R )-5-benzyl-2-tert-butyl-3-methyl-
imidazolidin-4-one (82.6 mg, 0.335 mmol), trifluoromethanesulfonic acid (30 µL, 0.335
mmol), and H2O (60 µL, 3.35 mmol) in CHCl3 (16.8 mL, 0.1 M) at room temperature.
The reaction mixture was cooled to -20 ˚C.  5-Triisopropylsilanyloxy-furan-2-carboxylic
acid methyl ester 6 (500 mg, 1.68 mmol) was added at -20 ˚C in 1 mL CHCl3.  The
reaction mixture was stirred for 40 h, filtered over a silica plug, and concentrated.  After
silica gel chromatography, aldehyde 10 was isolated as a pale yellow solid after
reconcentration from hexanes (278 mg, 65% yield, 22:1 d.r., 97% e.e.).  IR (film): 3103,
2956, 2849, 1783, 1739, 1603, 1437, 1247, 1189, 1086, 1031, 917.8, 820.2 cm-1; 1H
NMR (300 MHz, CDCl3) δ 9.72 (s, 1H, CHO), 7.48 (d, J = 5.4 Hz, 1H, CH=CH), 6.20
(d, J = 5.4 Hz, 1H, CH=CH), 3.94 (dd, J = 7.2, 4.8 Hz, 1H, CHCO2CH3), 3.80 (s, 3H,
CO2CH3), 3.73 (s, 3H, CO2CH3), 3.11 (dd, J = 19.2, 7.5 Hz, 1H, CHH-CHO), 2.55 (dd, J
= 18.6, 4.8 Hz, 1H, CHH-CHO); 13C NMR (75 MHz, CDCl3) δ 198.1, 170.5, 169.4,
166.9, 153.8, 122.9, 88.9, 53.8, 53.3, 43.5, 39.9; HRMS (EI+) exact mass calc’d for
(C11H12O7) requires m/z 256.0583, found m/z 256.0576.  [α]D = -124.0 (c = 0.97, CHCl3).
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The enantiomeric ratio was determined by GLC analysis of the aldehyde using a Bodman
Chiraldex Γ-TA  (30 m x 0.25 mm) column (155 ˚C, 1.0 mL/min); (2R,1’R) isomer tr =
62.8 min, (2S,1’S) isomer tr = 58.4 min.
(2S,1’S)-2-(1’-Methoxycarbonyl-undec-3’-enyl)-5-oxo-2,5-
dihydrofuran-2-carboxylic acid methyl ester.  Chromous chloride (383 mg, 3.12
mmol) and N,N-dimethyl formamide (243 µL, 3.12 mmol) were stirred in anhydrous THF
(7.8 mL) under an N2 atmosphere at room temperature for 1 h to generate the CrCl2:DMF
complex.5  1,1-diiodooctane6 (287 mg, 0.780 mmol) and aldehyde 10 (100 mg, 0.390
mmol) were added in 1.3 mL of anhydrous THF .  TLC analysis showed consumption of
the aldehyde after 3.5 h.  The reaction was quenched with H2O and the aqueous layer was
extracted three times with pentanes.  The pentane layers were dried (Na2SO4) and
concentrated.  The title compound was afforded as a white solid after silica gel
chromatography (77 mg, 65% yield).  IR (film):  2956, 2922, 2852, 1777, 1742, 1724,
1439, 1260, 1186, 1101, 968.8, 916.5, 833.0 cm-1; 1H NMR (300 MHz, CDCl3) δ 7.25 (d,
J = 5.4 Hz, 1H, CH=CH), 6.00 (d, J = 5.4 Hz, 1H, CH=CH), 5.22 (dt, J = 15.3, 6.6 Hz,
1H, CH2CH=CHCH2), 5.09 (dt, J = 15.3, 6.6 Hz, 1H, CH2CH=CHCH2), 3.58 (s, 3H,
CO2CH3), 3.50 (s, 3H, CO2CH3), 3.12 (dd, J = 8.1, 4.8 Hz, 1H, CHCO2CH3), 2.18 (m,
1H, CHHCH=CH), 2.03 (m, 1H, CHHCH=CH), 1.73 (dt, J  = 6.9, 6.0 Hz, 2H,
CH=CHCH2), 1.03 (m, 10H, (CH2)5), 0.66 (t, 3H, J = 6.6 Hz, CH2CH3); 13C NMR (75
MHz, CDCl3) δ 170.8, 170.2, 167.4, 153.3, 134.5, 125.3, 122.8, 89.6, 53.7, 52.5, 50.1,
32.7, 32.0, 29.5, 29.4, 29.3, 29.3, 22.9, 14.3; HRMS (EI) exact mass calc’d for (C19H28O6)
requires m/z 352.1886, found m/z 352.1881.  [α]D = -70.0 (c = 1.0, CHCl3).
(2S,1’S)-2-(1’-Methoxycarbonyl-undecyl)-5-oxo-tetrahydrofuran-2-
carboxylic acid methyl ester.  A 25 mL round bottom flask equipped with a magnetic
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stir bar and containing (2R,1’R)-2-(1’-Methoxycarbonyl-undec-3’-enyl)-5-oxo-2,5-
dihydrofuran-2-carboxylic acid methyl ester (100 mg, 0.284 mmol) and activated
palladium on carbon (10 mg) was charged with degassed EtOAc (2.8 mL, 0.1M).  The
system was evacuated and purged with H2 gas three times.  The reaction was stirred at
ambient temperature under a hydrogen atmosphere until TLC analysis showed the
reaction complete after 4.5 h, at which point the reaction mixture was filtered over a pad
of Celite and a pad of silica gel with EtOAc to afford the title compound as a clear oil
after concentration (101 mg, quantatative yield).  IR (film):  2955, 2926, 2855, 1796,
1740, 1456, 1436, 1269, 1230, 1165, 1060, 985.5, 896.9 cm-1; 1H NMR (300 MHz,
CDCl3) δ 3.79 (s, 3H, CO2CH3), 3.70 (s, 3H, CO2CH3), 3.11 (dd, J = 10.8, 3.3 Hz, 1H,
CHCO2CH3), 2.60 (m, 4H, CH2CH2CO2), 1.77 (m, 1H, CHCHH(CH2)8), 1.56 (m, 1H,
CHCHH(CH2)8), 1.25 (m, 16H, (CH2)8), 0.87 (t, 3H, J = 6.6 Hz, CH2CH3); 13C NMR (75
MHz, CDCl3) δ 175.3, 172.2, 170.6, 86.5, 60.7, 53.5, 52.3, 50.4, 32.1, 29.8, 29.8, 29.6,
29.6, 28.2, 28.1, 27.5, 27.3, 23.0, 14.4; HRMS (CI) exact mass calc’d for (C19H33O6)+
requires m/z 357.2277, found m/z 357.2273.  [α]D = +10.3 (c = 1.0, CHCl3).
(-)-5-Epi-spiculisporic acid (11). (2R,1’R)-2-(1’-Methoxycarbonyl-
undecyl)-5-oxo-tetrahydrofuran-2-carboxylic acid methyl ester (28.7 mg, 0.0805 mmol)
was taken up in 0.5 mL THF and 1 mL of 4N aqueous NaOH.  The biphasic mixture was
refluxed at 100 ˚C for 5.5 h and then cooled to room temperature.  The reaction mixture
was acidified with 1N aqueous HCl to pH=1.  The aqueous layer was extracted four times
with EtOAc.  The organic layers were concentrated to a white solid.  The hydrolyzed
intermediate was dissolved in a small amount of THF and 2 mL of 1N aqueous HCl was
added.  The reaction mixture was refluxed at 100 ˚C for 3.5 h, after which it was cooled
to room temperature and extracted four times with EtOAc.  The organic layers were dried
(Na2SO4) and concentrated to a white solid which was then recrystallized from hot water
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to yield (+)-5-epi-spiculisporic acid 11 as a white solid (20 mg, 76% yield).  IR (film):
2917, 2850, 1801, 1709, 1466, 1420, 1182, 1133, 1055, 953.8 cm-1; 1H NMR (300 MHz,
CD3OD) δ 3.03 (dd, J = 9.3, 4.2 Hz, 1H, CHCO2H), 2.57 (m, 4H, CH2CH2CO2C), 1.66
(m, 2H, CHCH2(CH2)8), 1.30 (m, 16H, (CH2)8), 0.90 (t, J = 6.6 Hz, 3H, CH2CH3); 13C
NMR (75 MHz, CD3OD) δ 178.4, 175.4, 173.8, 88.0, 51.9, 33.3, 30.9, 30.9, 30.7, 30.7,
30.7, 29.5, 29.1, 29.0, 28.3, 24.0, 14.7; HRMS (FAB+) exact mass calc’d for (C17H29O6)+
requires m/z 329.1964, found m/z 329.1962.  [α]D = -6.3 (c = 0.75, EtOH).
General procedure for reductive amination and heteroconjugate addition to
form 2,3,3’,4-tetrasubstituted piperidine adducts.  The γ-butenolide (1.0 equiv) was
taken up in THF (0.25 M).  (L)-α-Methylbenzylamine (2.0 equiv) was added to the
solution, followed by sodium triacetoxyborohydride (STAB, 1.5 equiv).  The reaction
was stirred vigorously at ambient temperature until TLC analysis showed consumption of
the aldehyde.  The reaction was quenched with a saturated aqueous solution of Rochelle’s
salt and stirred for 12-15 h at ambient temperature.  The aqueous phase was extracted
three times with EtOAc.  The organic layers were dried (Na2SO4) and concentrated.  The
2,3,3’,4-tetrasubstituted piperidine product was isolated after silica gel chromatography
(100% CH2Cl2).
(7aS,7R)-7a-Methyl-4-((1S)-1-phenylethyl)-7-propylhexahydro-furo[3,2-
b]pyridin-2-one.  Prepared according to the general procedure above using the methyl γ-
butenolide of 2-hexenal (Table 2, entry 2) (500 mg, 2.55 mmol), (L)-α-
methylbenzylamine (400 µL, 5.10 mmol), STAB (810 mg, 3.83 mmol), and THF (10.2
mL).  The title compound was isolated as a yellow oil (573 mg) in 75% yield.  IR (film):
2957, 2934, 2872, 2806, 1772, 1653, 1457, 1230, 1086, 943.4 cm-1; 1H NMR (300 MHz,
CDCl3) δ 7.30 (m, 5H, ArH), 3.44 (q, J = 6.6 Hz, 1H, NHCHAr), 3.25 (dd, J = 12.3, 7.8
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Hz, NHCHCH2), 3.03 (dt, J = 12.0, 3.3 Hz, 1H, NHCHHCH2), 2.72 (dd, J = 17.1, 12.6
Hz, 1H, CHCHHCO), 2.34 (dt, J =12.3, 3.0 Hz, 1H, NHCHHCH2), 2.08 (dd, J = 16.5,
7.2 Hz, 1H, CHCHHCO), 1.76 (dq, J = 13.2, 3.3 Hz, 1H, CH2CHHCH), 1.57 (m, 1H,
CHCH2CH2CH3), 1.40 (m, 2H, CH2CHHCH and CHHCH2CH3), 1.33 (d, J = 6.3 Hz, 3H,
NHCHCH3), 1.32 (s, 3H, CCH3), 1.16 (m, 3H, CHHCH2CH3), 0.85 (t, J = 7.2 Hz, 3H,
CH2CH3); 13C NMR (75 MHz, CDCl 3) δ 175.2, 144.1, 128.5 (2), 127.2, 126.7 (2), 85.9,
63.4, 62.1, 42.2, 41.5, 31.9, 28.3, 25.5, 21.4,20.7, 18.8, 14.4; HRMS (EI) exact mass
calc’d for (C19H27NO2) requires m/z 301.2043, found m/z 301.2042.  [α]D = −106.5 (c =
1.0, CHCl3).
The stereochemistry was confirmed by the presence of an nOe between H3 and H4
(7.3%), H4 and H7 (5.7%) and H3 and H7 (5.7%).  Furthermore, there were nOe
interactions between H5 and H1 (5.1%), H1 and the methyl group at the 3-piperidine
position (7.4%), and H5 and the methyl group at the 3-piperidine position (5.8%).
(7aS,7S)-7a-Methyl-7-phenyl-4-((1S)-1-phenylethyl)-hexahydro-furo[3,2-
b]pyridin-2-one.  Prepared according to the general procedure above using the methyl γ-
butenolide cinnamaldehyde (Table 2, Entry 4) (470 mg, 2.04 mmol), (L)-α-
methylbenzylamine (325 µL, 4.08 mmol), STAB (650 mg, 3.06 mmol), and THF (8.2
mL).  The uncyclized title compound was isolated as a yellow oil (406 mg) in 60% yield,
which cyclized to the title compound upon standing at room temperature for several days.
The product was isolated as colorless crystals.  IR (film): 3060, 3028, 2976, 2941, 2878,
2852, 1770, 1493, 1452, 1217, 1154, 933.2, 727.6, 700.3 cm-1; 1H NMR (300 MHz,
CH3
N
OH7 CH3H1
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H3C
O
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CDCl3) δ 7.36 (m, 10H, ArH), 3.94 (q, J = 6.6 Hz, 1H, NHCHAr), 3.47 (d, J = 4.8 Hz,
NHCHCH2), 2.87 (dd, J = 17.7, 5.1 Hz, 1H, NHCHHCH2), 2.73 (dd, J = 13.2, 4.5 Hz,
2H), 2.52 (m, 2H), 2.06 (m, 1H), 1.65 (dq, J = 13.2, 3.9 Hz, 1H), 1.41 (d, J = 6.6 Hz, 3H,
NHCHCH3), 1.26 (s, 3H, CCH3); 13C NMR (75 MHz, CDCl 3) δ 176.0, 143.0, 140.1,
129.4 (2), 128.0 (2), 127.9 (2), 127.0 (2), 126.7, 126.6, 85.6, 61.4, 56.2, 49.6, 42.7, 35.6,
27.6, 25.1, 11.9; HRMS (EI) exact mass calc’d for (C22H25NO2) requires m/z  335.1885,
found m/z 335.1890.  [α]D = −67.4 (c = 2.3, CHCl3).  The stereochemistry of the title
compound was confirmed by single crystal X-ray diffraction of the title compound (vide
infra).
(7aS,7R)-7a-Methyl-7-iso-propyl-4-((1S)-1-phenylethyl)hexahydro-furo[3,2-
b]pyridin-2-one.    Prepared according to the general procedure above using the methyl
γ-butenolide of 4-methyl-2-pentenal (Table 2, Entry 3) (620 mg, 3.16 mmol), (L)-α-
methylbenzylamine (500 µL, 6.32 mmol), STAB (1.00 g, 4.74 mmol), and THF (12.6
mL).  The title compound was isolated as a yellow oil (503 mg) in 54% yield.  IR (film):
2960, 2875, 2805, 1770, 1454, 1381, 1232, 1080, 943.4, 765.9, 702.2 cm-1; 1H NMR (300
MHz, CDCl3) δ 7.29 (m, 5H, ArH), 3.58 (dd, J = 12.3, 7.2 Hz, 1H, NHCHCH2), 3.49 (q,
J = 6.6 Hz, NCHAr), 2.76 (dd, J = 16.5, 12.0 Hz, 1H, CHCHHCO), 2.62 (dt, J = 12.3,
3.3 Hz, 1H, NHCHHCH2), 2.22 (dt, J =12.0, 2.7 Hz, 1H, NHCHHCH2), 2.15 (dd, J =
17.1, 7.8 Hz, 1H CHCHHCO), 1.76 (sept, J = 6.6 Hz, 1H, CH(CH3)2), 1.59 (dq, J = 12.3,
3.0 Hz, 1H, CH2CHHCH), 1.52 (s, 3H, CCH3), 1.31 (d, J = 6.6 Hz, 3H, NHCHAr), 1.18
(2H, m, CH2CHi-Pr and CH2CHHCH), 1.00 (d, J = 7.2 Hz, 3H, CH(CH3) (CH3)), 0.87
(d, J = 6.6 Hz, 3H, CH(CH3) (CH3)); 13C NMR (75 MHz, CDCl 3) δ 174.9, 144.6, 128.2
(2), 126.9, 127.7 (2), 86.6, 63.2, 62.2, 47.5, 44.1, 27.7, 25.7, 25.5, 23.1, 20.7, 20.5, 20.0;
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HRMS (EI) exact mass calc’d for (C19H27NO2) requires m/z 301.2042, found m/z
301.2045.  [α]D = −106.5 (c = 1.0, CHCl3).
The stereochemistry was confirmed by the presence of an nOe between H3 and H4
(13.2%), H4 and H7 (5.1%) and H3 and H7 (7.6%).  Furthermore, there were nOe
interactions between H5 and H1 (5.5%), H1 and the methyl group at the 3-piperidine
position (6.6%), H8 and the methyl group at the 3-piperidine position (3.2%), and H1 and
H8 (2.2%)
(5S,1'R)-5-Methyl-5-[1'-methyl-3'-((1S)-1-phenylethylamino)-propyl]-5H-
furan-2-one hydrochloride. The methyl γ-butenolide of crotonaldehyde (Table 2, Entry
1) (206 mg, 1.23 mmol) was taken up in THF (4.9 mL, 0.25 M).  (L)-α-
Methylbenzylamine (195 µL, 2.45 mmol) was added to the solution, followed by addition
of STAB (389 mg, 3.81.843 mmol).  The reaction was stirred at ambient temperature for
15 min, after which saturated aqueous NaHCO3 was added and stirred for an additional
hour.  The aqueous mixture was extracted with EtOAc three times, dried (MgSO4) and
concentrated.  The uncyclized reductive amination product was isolated after silica gel
chromatography (1% Et3N/99% CH2Cl2 then 2% Et3N/3% MeOH/95% CH2Cl2 flush) as a
yellow oil (199 mg) in 60% yield.  The hydrochloric acid salt of the reductive amination
product was prepared by taking up the amine (61.4 mg, 0.225 mmol) in Et2O and adding
113 µL of a 2M solution of HCl in Et2O.  The HCl salt precipitated out and the solid was
filtered and washed with Et2O to afford the title compound as a white powder (67.4 mg,
CH3
N
OH7
H1
Ph
H3C
O
H6
H4
H2
H3
H5
CH3
CH3
H8
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quantative yield).  IR (film): 2976, 2734, 2464, 1752, 1588, 1456, 1382, 1241, 1120,
952.2, 822.4, 766.6  cm-1; 1H NMR (300 MHz, CD2Cl2) δ 10.28 (bs, 1H, NHH), 9.95 (bs,
1H, NHH), 7.64 (m, 2H, CH=CH and ArH), 7.44 (m, 4H, ArH), 6.00 (d, J = 5.4 Hz,
CH=CH), 4.24 (m, 1H, NHCHAr), 2.82 (m, 1H), 2.63 (m, 1H), 2.12 (m, 1H), 1.85 (d, J =
6.6 Hz, 3H, NHCHCH3), 1.82 (m, 1H), 1.40 (s, 3H, CCH3), 0.85 (t, J = 6.6 Hz, 3H,
CHCH3); 13C NMR (75 MHz, CD2Cl2) δ 172.3, 159.7, 136.5, 129.7 (2), 129.6, 128.3 (2),
121.5, 91.2, 59.0, 44.3, 38.8, 27.8, 22.6, 21.0, 15.0; HRMS (FAB+, M-Cl) exact mass
calc’d for (C17H24NO2)+ requires m/z 274.1807, found m/z 274.1800.  [α]D = +17.0 (c =
0.12, MeOH).  The stereochemistry of the title compound was confirmed by single
crystal X-ray diffraction of crystals (vide infra) obtained from heating the salt into
acetonitrile and allowing slow vapor diffusion in a toluene-filled chamber.
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